Is HCAT or BEAT more profitable?

HeartBeam has a net margin of 0.00% compared to Health Catalyst's net margin of -87.69%. Health Catalyst's return on equity of -3.52% beat HeartBeam's return on equity. Company Net Margins Return on Equity Return on Assets Health Catalyst -87.69% -3.52% -1.77% HeartBeam N/A -1,034.04% -434.40%

Does the media refer more to HCAT or BEAT?

In the previous week, HeartBeam had 4 more articles in the media than Health Catalyst. MarketBeat recorded 7 mentions for HeartBeam and 3 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.94 beat HeartBeam's score of 0.23 indicating that Health Catalyst is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HeartBeam 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Is BEAT or AMWL more profitable?

HeartBeam has a net margin of 0.00% compared to American Well's net margin of -37.02%. American Well's return on equity of -32.11% beat HeartBeam's return on equity. Company Net Margins Return on Equity Return on Assets HeartBeam N/A -1,034.04% -434.40% American Well -37.02% -32.11% -24.12%

Does the media refer more to BEAT or AMWL?

In the previous week, HeartBeam had 3 more articles in the media than American Well. MarketBeat recorded 7 mentions for HeartBeam and 4 mentions for American Well. American Well's average media sentiment score of 0.88 beat HeartBeam's score of 0.23 indicating that American Well is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HeartBeam 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral American Well 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, CCLD or BEAT?

CareCloud has higher revenue and earnings than HeartBeam. HeartBeam is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareCloud $120.50M 0.80 $10.80M $0.11 20.64 HeartBeam N/A N/A -$21.01M -$0.56 N/A

Is CCLD or BEAT more profitable?

CareCloud has a net margin of 7.87% compared to HeartBeam's net margin of 0.00%. CareCloud's return on equity of 24.05% beat HeartBeam's return on equity. Company Net Margins Return on Equity Return on Assets CareCloud 7.87% 24.05% 16.38% HeartBeam N/A -1,034.04% -434.40%

Does the media refer more to CCLD or BEAT?

In the previous week, HeartBeam had 5 more articles in the media than CareCloud. MarketBeat recorded 7 mentions for HeartBeam and 2 mentions for CareCloud. CareCloud's average media sentiment score of 1.65 beat HeartBeam's score of 0.23 indicating that CareCloud is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareCloud 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive HeartBeam 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Is OM or BEAT more profitable?

HeartBeam has a net margin of 0.00% compared to Outset Medical's net margin of -63.65%. Outset Medical's return on equity of -56.13% beat HeartBeam's return on equity. Company Net Margins Return on Equity Return on Assets Outset Medical -63.65% -56.13% -27.45% HeartBeam N/A -1,034.04% -434.40%

Is BEAT or PIII more profitable?

HeartBeam has a net margin of 0.00% compared to P3 Health Partners' net margin of -8.57%. P3 Health Partners' return on equity of -302.33% beat HeartBeam's return on equity. Company Net Margins Return on Equity Return on Assets HeartBeam N/A -1,034.04% -434.40% P3 Health Partners -8.57% -302.33% -19.99%

Does the media refer more to BEAT or PIII?

In the previous week, HeartBeam had 4 more articles in the media than P3 Health Partners. MarketBeat recorded 7 mentions for HeartBeam and 3 mentions for P3 Health Partners. P3 Health Partners' average media sentiment score of 1.48 beat HeartBeam's score of 0.23 indicating that P3 Health Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HeartBeam 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral P3 Health Partners 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

HeartBeam (BEAT) Competitors

$0.73 -0.02 (-2.76%)

Closing price 04:00 PM Eastern

Extended Trading

$0.74 +0.01 (+0.78%)

As of 07:40 PM Eastern

Compare

BEAT vs. HCAT, AMWL, CCLD, OM, and PIII

Should you buy HeartBeam stock or one of its competitors? MarketBeat compares HeartBeam with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with HeartBeam include Health Catalyst (HCAT), American Well (AMWL), CareCloud (CCLD), Outset Medical (OM), and P3 Health Partners (PIII). These companies are all part of the "medical info sys" industry.

How does HeartBeam compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and HeartBeam (NASDAQ:BEAT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends.

HeartBeam has a net margin of 0.00% compared to Health Catalyst's net margin of -87.69%. Health Catalyst's return on equity of -3.52% beat HeartBeam's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-87.69%	-3.52%	-1.77%
HeartBeam	N/A	-1,034.04%	-434.40%

HeartBeam has lower revenue, but higher earnings than Health Catalyst. HeartBeam is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.49	-$177.97M	-$3.72	N/A
HeartBeam	N/A	N/A	-$21.01M	-$0.56	N/A

In the previous week, HeartBeam had 4 more articles in the media than Health Catalyst. MarketBeat recorded 7 mentions for HeartBeam and 3 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.94 beat HeartBeam's score of 0.23 indicating that Health Catalyst is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HeartBeam	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 7.8% of HeartBeam shares are held by institutional investors. 19.4% of Health Catalyst shares are held by company insiders. Comparatively, 18.0% of HeartBeam shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Health Catalyst has a beta of 1.66, indicating that its stock price is 66% more volatile than the broader market. Comparatively, HeartBeam has a beta of -0.86, indicating that its stock price is 186% less volatile than the broader market.

Health Catalyst currently has a consensus price target of $2.84, indicating a potential upside of 37.24%. HeartBeam has a consensus price target of $4.33, indicating a potential upside of 494.18%. Given HeartBeam's stronger consensus rating and higher possible upside, analysts plainly believe HeartBeam is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23
HeartBeam	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.63

Summary

Health Catalyst beats HeartBeam on 8 of the 15 factors compared between the two stocks.

How does HeartBeam compare to American Well?

HeartBeam (NASDAQ:BEAT) and American Well (NYSE:AMWL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

HeartBeam presently has a consensus target price of $4.33, indicating a potential upside of 494.18%. American Well has a consensus target price of $7.20, indicating a potential downside of 23.40%. Given HeartBeam's stronger consensus rating and higher probable upside, research analysts clearly believe HeartBeam is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartBeam	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.63
American Well	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

HeartBeam has higher earnings, but lower revenue than American Well. American Well is trading at a lower price-to-earnings ratio than HeartBeam, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartBeam	N/A	N/A	-$21.01M	-$0.56	N/A
American Well	$249.32M	0.62	-$95.70M	-$5.42	N/A

In the previous week, HeartBeam had 3 more articles in the media than American Well. MarketBeat recorded 7 mentions for HeartBeam and 4 mentions for American Well. American Well's average media sentiment score of 0.88 beat HeartBeam's score of 0.23 indicating that American Well is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HeartBeam	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
American Well	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

7.8% of HeartBeam shares are held by institutional investors. Comparatively, 56.1% of American Well shares are held by institutional investors. 18.0% of HeartBeam shares are held by company insiders. Comparatively, 12.8% of American Well shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

HeartBeam has a beta of -0.86, indicating that its share price is 186% less volatile than the broader market. Comparatively, American Well has a beta of 1.69, indicating that its share price is 69% more volatile than the broader market.

HeartBeam has a net margin of 0.00% compared to American Well's net margin of -37.02%. American Well's return on equity of -32.11% beat HeartBeam's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartBeam	N/A	-1,034.04%	-434.40%
American Well	-37.02%	-32.11%	-24.12%

Summary

HeartBeam beats American Well on 10 of the 16 factors compared between the two stocks.

How does HeartBeam compare to CareCloud?

CareCloud (NASDAQ:CCLD) and HeartBeam (NASDAQ:BEAT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

10.2% of CareCloud shares are held by institutional investors. Comparatively, 7.8% of HeartBeam shares are held by institutional investors. 14.8% of CareCloud shares are held by company insiders. Comparatively, 18.0% of HeartBeam shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

CareCloud currently has a consensus price target of $3.25, indicating a potential upside of 43.17%. HeartBeam has a consensus price target of $4.33, indicating a potential upside of 494.18%. Given HeartBeam's stronger consensus rating and higher probable upside, analysts clearly believe HeartBeam is more favorable than CareCloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
HeartBeam	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.63

CareCloud has a net margin of 7.87% compared to HeartBeam's net margin of 0.00%. CareCloud's return on equity of 24.05% beat HeartBeam's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	7.87%	24.05%	16.38%
HeartBeam	N/A	-1,034.04%	-434.40%

CareCloud has higher revenue and earnings than HeartBeam. HeartBeam is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$120.50M	0.80	$10.80M	$0.11	20.64
HeartBeam	N/A	N/A	-$21.01M	-$0.56	N/A

In the previous week, HeartBeam had 5 more articles in the media than CareCloud. MarketBeat recorded 7 mentions for HeartBeam and 2 mentions for CareCloud. CareCloud's average media sentiment score of 1.65 beat HeartBeam's score of 0.23 indicating that CareCloud is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareCloud	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
HeartBeam	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

CareCloud has a beta of 1.5, suggesting that its stock price is 50% more volatile than the broader market. Comparatively, HeartBeam has a beta of -0.86, suggesting that its stock price is 186% less volatile than the broader market.

Summary

CareCloud beats HeartBeam on 10 of the 16 factors compared between the two stocks.

How does HeartBeam compare to Outset Medical?

Outset Medical (NASDAQ:OM) and HeartBeam (NASDAQ:BEAT) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

In the previous week, HeartBeam had 6 more articles in the media than Outset Medical. MarketBeat recorded 7 mentions for HeartBeam and 1 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.94 beat HeartBeam's score of 0.23 indicating that Outset Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Outset Medical	Positive
HeartBeam	Neutral

Outset Medical has a beta of 1.95, suggesting that its stock price is 95% more volatile than the broader market. Comparatively, HeartBeam has a beta of -0.86, suggesting that its stock price is 186% less volatile than the broader market.

HeartBeam has lower revenue, but higher earnings than Outset Medical. HeartBeam is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.79	-$81.65M	-$4.16	N/A
HeartBeam	N/A	N/A	-$21.01M	-$0.56	N/A

7.8% of HeartBeam shares are held by institutional investors. 2.5% of Outset Medical shares are held by company insiders. Comparatively, 18.0% of HeartBeam shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

HeartBeam has a net margin of 0.00% compared to Outset Medical's net margin of -63.65%. Outset Medical's return on equity of -56.13% beat HeartBeam's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
HeartBeam	N/A	-1,034.04%	-434.40%

Outset Medical presently has a consensus target price of $10.00, indicating a potential upside of 96.08%. HeartBeam has a consensus target price of $4.33, indicating a potential upside of 494.18%. Given HeartBeam's stronger consensus rating and higher possible upside, analysts plainly believe HeartBeam is more favorable than Outset Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
HeartBeam	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.63

Summary

HeartBeam beats Outset Medical on 10 of the 16 factors compared between the two stocks.

How does HeartBeam compare to P3 Health Partners?

HeartBeam (NASDAQ:BEAT) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, dividends, profitability and institutional ownership.

HeartBeam currently has a consensus price target of $4.33, indicating a potential upside of 494.18%. P3 Health Partners has a consensus price target of $14.00, indicating a potential upside of 26.47%. Given HeartBeam's stronger consensus rating and higher probable upside, equities analysts clearly believe HeartBeam is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartBeam	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.63
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

HeartBeam has a net margin of 0.00% compared to P3 Health Partners' net margin of -8.57%. P3 Health Partners' return on equity of -302.33% beat HeartBeam's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartBeam	N/A	-1,034.04%	-434.40%
P3 Health Partners	-8.57%	-302.33%	-19.99%

In the previous week, HeartBeam had 4 more articles in the media than P3 Health Partners. MarketBeat recorded 7 mentions for HeartBeam and 3 mentions for P3 Health Partners. P3 Health Partners' average media sentiment score of 1.48 beat HeartBeam's score of 0.23 indicating that P3 Health Partners is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HeartBeam	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
P3 Health Partners	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HeartBeam has higher earnings, but lower revenue than P3 Health Partners. HeartBeam is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartBeam	N/A	N/A	-$21.01M	-$0.56	N/A
P3 Health Partners	$1.46B	0.05	-$147.95M	-$38.60	N/A

HeartBeam has a beta of -0.86, suggesting that its share price is 186% less volatile than the broader market. Comparatively, P3 Health Partners has a beta of 1.6, suggesting that its share price is 60% more volatile than the broader market.

7.8% of HeartBeam shares are held by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are held by institutional investors. 18.0% of HeartBeam shares are held by insiders. Comparatively, 10.9% of P3 Health Partners shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

HeartBeam beats P3 Health Partners on 10 of the 16 factors compared between the two stocks.

Get HeartBeam News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BEAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BEAT vs. The Competition

Export

Metric	HeartBeam	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$40.48M	$1.81B	$6.79B	$12.53B
Dividend Yield	N/A	N/A	2.66%	6.15%
P/E Ratio	-1.30	81.12	27.46	25.26
Price / Sales	N/A	7.85	582.98	118.84
Price / Cash	N/A	24.83	48.53	58.59
Price / Book	12.16	5.79	10.95	6.61
Net Income	-$21.01M	-$54.76M	$3.57B	$336.83M
7 Day Performance	5.21%	7.08%	2.58%	2.52%
1 Month Performance	-17.49%	-0.02%	1.67%	0.44%
1 Year Performance	-40.47%	5.08%	35.96%	29.40%

HeartBeam Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BEAT HeartBeam	4.6286 of 5 stars	$0.73 -2.8%	$4.33 +494.2%	-39.8%	$40.48M	N/A	N/A	1,700	News Coverage
HCAT Health Catalyst	4.0395 of 5 stars	$2.14 +7.3%	$2.84 +33.0%	-47.2%	$158.49M	$311.14M	N/A	1,200
AMWL American Well	2.4565 of 5 stars	$9.37 +2.7%	$7.20 -23.1%	+4.2%	$154.99M	$249.32M	N/A	1,040
CCLD CareCloud	4.3077 of 5 stars	$2.26 +6.4%	$3.25 +44.1%	-10.2%	$95.82M	$120.50M	20.50	3,650	Positive News
OM Outset Medical	3.1084 of 5 stars	$4.91 +13.6%	$10.00 +103.7%	-77.5%	$90.85M	$119.48M	N/A	520

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BEAT) was last updated on 7/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HeartBeam (BEAT) Competitors

BEAT vs. HCAT, AMWL, CCLD, OM, and PIII

How does HeartBeam compare to Health Catalyst?

Summary

How does HeartBeam compare to American Well?

Summary

How does HeartBeam compare to CareCloud?

Summary

How does HeartBeam compare to Outset Medical?

Summary

How does HeartBeam compare to P3 Health Partners?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BEAT vs. The Competition

HeartBeam Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HeartBeam (BEAT) Competitors

BEAT vs. HCAT, AMWL, CCLD, OM, and PIII

How does HeartBeam compare to Health Catalyst?

Is HCAT or BEAT more profitable?

Which has preferable earnings and valuation, HCAT or BEAT?

Does the media refer more to HCAT or BEAT?

Do insiders and institutionals have more ownership in HCAT or BEAT?

Which has more risk and volatility, HCAT or BEAT?

Do analysts prefer HCAT or BEAT?

Summary

How does HeartBeam compare to American Well?

Do analysts prefer BEAT or AMWL?

Which has stronger valuation and earnings, BEAT or AMWL?

Does the media refer more to BEAT or AMWL?

Do insiders & institutionals have more ownership in BEAT or AMWL?

Which has more risk & volatility, BEAT or AMWL?

Is BEAT or AMWL more profitable?

Summary

How does HeartBeam compare to CareCloud?

Do institutionals and insiders have more ownership in CCLD or BEAT?

Do analysts recommend CCLD or BEAT?

Is CCLD or BEAT more profitable?

Which has stronger earnings and valuation, CCLD or BEAT?

Does the media refer more to CCLD or BEAT?

Which has more volatility and risk, CCLD or BEAT?

Summary

How does HeartBeam compare to Outset Medical?

Does the media refer more to OM or BEAT?

Which has more volatility & risk, OM or BEAT?

Which has higher valuation and earnings, OM or BEAT?

Do institutionals & insiders have more ownership in OM or BEAT?

Is OM or BEAT more profitable?

Do analysts recommend OM or BEAT?

Summary

How does HeartBeam compare to P3 Health Partners?

Do analysts recommend BEAT or PIII?

Is BEAT or PIII more profitable?

Does the media refer more to BEAT or PIII?

Which has preferable earnings & valuation, BEAT or PIII?

Which has more risk and volatility, BEAT or PIII?

Do institutionals and insiders have more ownership in BEAT or PIII?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BEAT vs. The Competition

HeartBeam Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools